Pfizer-BioNTech has become the sixth vaccine to be approved by Thailand’s Food and Drug Administration (TFDA), for emergency use in the country, said TFDA Secretary-General Paisal Dunkhum today (Thursday).
Pfizer’s “Comirnaty” vaccine is an mRNA vaccine which encodes a mutated form of the spike protein found on the surface of the SARS-CoV-2 virus, which causes COVID-19, producing an immune response. It is recommended for people aged 12 and over and is administered in two doses, with a dosing interval of three weeks.
The five other vaccines approved by the TFDA are Sinovac and Sinopharm from China, Moderna and Johnson & Johnson from the United States and the British-Swedish Oxford-AstraZeneca.
According to Public Health Minister Anutin Charnvirakul, 20 million doses of Pfizer have been ordered, with deliveries expected in the last quarter of this year.
Thailand plans to administer the vaccine to youths aged 12-18.
